Programme

Programme

  • 10:00- 10:30  Arrival of participants & welcome coffee
  • 10:30 - 10:40  Welcome by moderator Hans Bender. Objectives of the day by Charles-François Gaudefroy, A.I.S.E. President.
  • 10:40 - 10:55  European Commission (DG GROW), Reinhard Büscher, Head of the Chemicals Unit : Safe use of chemicals: the potential of Better Regulation and the fitness check of chemicals legislation
  • 10:55 - 11:05  Update on the study on the regulatory fitness of chemicals legislation , with focus on the case study on consumer understanding and relevance of safety information on product labels, Linda-Jean Cockcroft, RPA.
  • 11:05 - 11:20  Perspective from consumers/surveys to date on current labelling system – Valérie Séjourné, A.I.S.E.
  • 11:20 - 11:35 Perspective from poison control centres – Fabrizio Sesana (Milano PCC): Distinguishing between consumer information and medical personnel information
  • 11:35 - 11:50  Testimonial from an A.I.S.E. company on label complexity and administration – Paul Clohessy, P&G for A.I.S.E.
  • 11:50 - 12:00  Testimonial from a public authority on consumer education  activities – Peter Dekker, Nederlandse Voedsel-en Warenautoriteit (NVWA - The Netherlands)
  • 12:00 - 12:30  Other relevant insights: recent US/ASTM research, Lori Dixon (by phone); feedback from related DU sectors, Alain D’Haese (Aerosols/FEA), Janice Robinson (paint/CEPE)
  • 12:30 - 13:00   Discussion
  • 13:00 - 14:00   Lunch
  • 14:00-15:30 Sub group discussion 1
Focus on consumer info - By Hans Bender:
Perspective from market research agency by Pedro Zaragoza, Synapses Quali, reporting on the planned qualitative market research due in June 2016 commissionned by A.I.S.E.
- Discussion on: planned research, assumptions based on today’s situation; what works, what does not work ;  validation and/or comments to the interview guide
-Possibly brainstorm on the ideal detergents product label for consumers.

Sub group discussion 2
Focus on medical personnel info - By Geert Boeije:
Discussions with PCCs, GP, Dermatologists, etc - Discussion on their reactions based on today’s situation; what works, what does not work
-Input from ESCD
-Which expectations do we get from the medical community as regards adequate labelling information?
-What info /gradation would be needed?

 

  • 15:30 - 16:00   Debrief from sub groups
  • 16:00 - 16:30   Conclusions and next steps